|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities | ||
| Net loss | ||
| Impairment of goodwill | ||
| Gain on settlement of accrued liabilities | ||
| Impairment of goodwill | ||
| Gain on settlement of notes payable and accrued liabilities | ||
| Allowance on note receivable | ||
| Changes in assets and liabilities | ||
| Accounts payable and accrued liabilities | ||
| Accounts payable and accrued liabilities - related party | ||
| Net cash used in operating activities | ||
| Cash Flows from Financing Activities: | ||
| Common stock issued for cash | ||
| Proceeds from notes payable | ||
| Net cash used in financing activities | ||
| Net increase in cash | ||
| Cash, beginning of period | ||
| Cash, end of period | ||
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | ||
| Cash paid for taxes | ||
| SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
| Shares issued for asset purchase agreement | ||
| Shares issued to settle debt | ||
| Shares issued to acquire intangible assets |
Loading...
